United Therapeutics | UTHR - Market Capitalization

Stock Price
475.46
Daily Change
0.46 0.10%
Monthly
-2.91%
Yearly
34.53%
Q1 Forecast
455.03

United Therapeutics reported $22.35B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amarin USD 341M 4M Sep/2025
Ardelyx USD 1.33B 390M Sep/2025
Baxter International USD 11.7B 3.84B Sep/2025
Bayer EUR 27.23B 2.14B Sep/2025
Biogen USD 20.54B 2.13B Sep/2025
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Gilead Sciences USD 137.73B 184M Sep/2025
GlaxoSmithKline GBP 64.04B 7.8B Sep/2025
Halozyme Therapeutics USD 8.58B 2.17B Sep/2025
Insmed USD 30.44B 11.35B Sep/2025
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
J&J USD 500.24B 67.44B Dec/2025
Moderna USD 10.09B 581M Sep/2025
Pfizer USD 145.87B 10.78B Feb/2026
PTC Therapeutics USD 4.88B 1B Sep/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
United Therapeutics USD 18.96B 6B Sep/2025
Vertex Pharmaceuticals USD 100.41B 13.91B Sep/2025